Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral fish oil immune modulation in Crohn's disease
2013-001212-30Phase 2Active
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fish oil concentrate in Crohn's disease (2 arms). Primary endpoint: TNF-alpha production change. Started Jun 2013; status: active.
02
Drugs
fish oil concentrate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2013-001212-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001212-30.